The research discussed in this episode focuses on how low doses of the drug ketamine produce fast and long-term antidepressant effects and identifies the gene (MeCP2) and processes in the brain that are involved.
VKC Researcher: Lisa Monteggia, Ph.D., Barlow Family Director of the Vanderbilt Brain Institute; Professor of Pharmacology
Interviewer: Jeffrey L. Neul, M.D., Ph.D., Annette Schaffer Eskind Chair and Director, Vanderbilt Kennedy Center; Professor of Pediatrics, Division of Neurology, Pharmacology, and Special Education
Information
- Show
- FrequencyUpdated Monthly
- PublishedSeptember 2, 2021 at 1:00 PM UTC
- Length30 min
- Season2
- Episode1
- RatingClean
